Detection of endpoints and biomarkers of repeated dose toxicity using in vitro systems (DETECTIVE)
Owner/Developer: European Commission and Cosmetics Europe
Assessment of repeated dose toxicity is a standard requirement in human safety evaluation and relies on animal testing as no alternatives are currently accepted for regulatory purposes. An integrated research strategy for the replacement of animal tests needs to comprise the development of biomarkers of long-term toxicity in human target cells. To this aim, the DETECTIVE project will set up a screening pipeline of high content, high throughput as well as classical functional and “-omics” technologies to identify and investigate human biomarkers in cellular models for repeated dose in vitro testing.
|Channel:||Face-to-face - Website - Printed|
|Audience:||Scientists - Regulators - Industry - Researchers|
|User access:||Open access|
|Purpose:||Regulatory testing - Toxicological and safety evaluation - Method development|
|Technology/Tools:||High throughput screening - High content screening - Omics - Alternative test methods (in vitro)|
Did you find what you were looking for?Yes, I found it! No, I did not!
Thanks for your feedback! Please note that we cannot respond unless you supply your email address.
What are you looking for?
Please give us your feedback so we can improve the information on the page. Thank you in advance for your help. Please add your email address if you would like a reply.Please contact us by email if you have any questions.